Keren Haruvi

Board Chair
Association for Accessible Medicines (AAM)

Keren Haruvi is AAM Board Chair and President of Sandoz North America. In her role at Sandoz, she leads Sandoz’s largest commercial and country organization – the United States – which is responsible for approximately a quarter of the global revenue for Sandoz Inc. She also oversees Sandoz commercial operations in Canada, and is a member of the Global Sandoz Leadership Team and Executive Committee.

Prior to joining Sandoz, Keren served as Global Head of M&A at Novartis International AG. Her early career began at Teva Pharmaceutical Industries where she steadily advanced in leadership roles to Senior VP, Global Business Development and Alliance Management.

Keren is a value creator in the biopharmaceutical space. She brings 17 years of experience in the pharmaceutical industry marked by success leading major M&A deals, enterprise innovations and complex market strategies for large-scale, sustainable growth.

Keren holds an MBA in Finance from Bar Ilan University and Bachelor’s degrees in Economics and Chemistry from Tel Aviv University.

Early bird tickets
available now